• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT TSH REAGENT KIT; RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT TSH REAGENT KIT; RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE Back to Search Results
Model Number 7K62-30
Medical Device Problem Code Low Test Results (2458)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/12/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Complete information from section a1 patient identifier: sid (b)(6) an evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event or Problem Description
The customer observed falsely depressed architect tsh results when compared to results from another method.The following data was provided: sid (b)(6).Initial result tsh 4.53 iu/l, retested on another instrument (sn isr54829) result tsh 10.64 iu/l.Retested on roche cobas result tsh 16.6 iu/l.No impact to patient management was reported.
 
Event or Problem Description
The customer observed falsely depressed architect tsh results when compared to results from another method.The following data was provided: sid (b)(6).Initial result tsh 4.53 iu/l, retested on another instrument (sn isr54829) result tsh 10.64 iu/l.Retested on roche cobas result tsh 16.6 iu/l.No impact to patient management was reported.
 
Additional Manufacturer Narrative
Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.Return testing was not performed as returns were not available.Device history record review was performed on lot 48544ud00, which did not show any potential non-conformances, deviations, or non-conformances.Trending review did not identify any trends.The ticket search by lot indicates that the reagent lots performs as expected for this product.Labeling review concludes that the issue is adequately addressed.Accuracy testing met acceptance and validity criteria for lot 48544ud00.Based on the investigation, no systemic issue or deficiency of the architect tsh assay was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT TSH REAGENT KIT
Common Device Name
RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI   N39E932
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key17020796
Report Number3005094123-2023-00138
Device Sequence Number7150939
Product Code JLW
UDI-Device Identifier00380740014247
UDI-Public00380740014247
Combination Product (Y/N)N
Initial Reporter CountryEZ
PMA/510(K) Number
K983442
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 07/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/05/2024
Device Model Number7K62-30
Device Catalogue Number07K62-30
Device Lot Number48544UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 05/12/2023
Supplement Date Received by Manufacturer06/26/2023
Initial Report FDA Received Date05/30/2023
Supplement Report FDA Received Date07/05/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/10/2023
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARC I2000SR INST,03M74-02,ISR54833 AND ISR54829; ARC I2000SR INST,03M74-02,ISR54833 AND ISR54829
Patient SexUnknown
-
-